|
|
Volumn 31, Issue 6, 2017, Pages 848-848.e1
|
|
SnapShot: Immune Checkpoint Inhibitors
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
GAMMA INTERFERON;
INDOLEAMINE 2,3 DIOXYGENASE;
INTERFERON REGULATORY FACTOR 1;
JANUS KINASE 3;
PROGRAMMED DEATH 1 LIGAND 1;
STAT1 PROTEIN;
STAT3 PROTEIN;
T LYMPHOCYTE RECEPTOR;
INTERFERON;
ANTIPROLIFERATIVE ACTIVITY;
CANCER CELL;
CELLULAR IMMUNITY;
GROWTH DISORDER;
HUMAN;
IMMUNE EVASION;
IMMUNE RESPONSE;
IMMUNITY;
IMMUNOCOMPETENT CELL;
IMMUNOLOGICAL TOLERANCE;
IMMUNOREGULATION;
LYMPHOCYTE PROLIFERATION;
MAJOR HISTOCOMPATIBILITY COMPLEX;
NATURAL KILLER CELL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE;
T LYMPHOCYTE ACTIVATION;
ADAPTIVE IMMUNITY;
CELL CYCLE CHECKPOINT;
DRUG EFFECTS;
DRUG RESISTANCE;
IMMUNOLOGY;
IMMUNOTHERAPY;
NEOPLASMS;
PHYSIOLOGY;
PROCEDURES;
ADAPTIVE IMMUNITY;
CELL CYCLE CHECKPOINTS;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
IMMUNOTHERAPY;
INTERFERONS;
NEOPLASMS;
|
|
EID: 85020645133
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccell.2017.05.010 Document Type: Short Survey |
|
Times cited : (240)
|
|
References (0)
|